Post Your Abstract In The Discussion Board And Discuss Why

Post Your Abstract In The Discussion Board And Discuss Why You Chose T

Post your abstract in the discussion board and discuss why you chose this topic and how it relates to research you plan to continue or to your future career. REPLY TO MY CLASSMATE’S RESPONSE TO THE ABOVE QUESTION AND EXPLAIN WHY YOU AGREE? (A MINIMUM OF 125 WORDS or MORE EACH QUESTION)

Paper For Above instruction

The discussion emphasizes selecting a research topic related to multiple myeloma, particularly focusing on its impact on elderly patients, as inspired by a personal connection. The student chooses this topic due to their father's battle with the disease, highlighting the need to explore treatment plans that improve quality of life with fewer adverse effects. This research aims to analyze different treatment options, especially in the context of aging populations, and evaluate their effectiveness and safety. The plan involves using mixed methods research, including interviews, to gather comprehensive data on patient experiences and treatment outcomes. The student also demonstrates awareness of ethical considerations, referencing the Belmont Report to ensure protection of human subjects. The pursuit of this research aligns with their future career goals in healthcare or medical research, aiming to develop or identify treatments that minimize side effects and enhance patients’ quality of life, especially for vulnerable elderly populations.

Paper For Above instruction

In selecting a research topic related to multiple myeloma and its effects on elderly patients, I am driven by a personal motivation rooted in my father’s ongoing battle with this incurable disease. His experience has profoundly impacted my understanding of the complexities involved in treating older adults with multiple myeloma, a disease that primarily affects those over 60 years old. The treatment journey has been arduous, involving chemotherapy, bone marrow transplants, and various medications aimed at managing symptoms and prolonging quality of life. Witnessing his physical decline, including bone fragility and reduced mobility, has fueled my desire to explore innovative treatment options that could potentially improve his quality of life and those of similar patients. My focus is on understanding how current treatment regimens impact elderly patients and whether combining therapies with supportive medications can mitigate side effects while maintaining efficacy.

Researching this topic is essential because elderly patients often experience diminished physical, mental, and social well-being, which complicates treatment outcomes. The potential for adverse effects and the increased vulnerability of this population necessitate a nuanced understanding of existing treatment protocols. As a future healthcare professional or researcher, I aim to contribute valuable insights that can enhance personalized treatment plans for elderly patients. By reviewing existing literature, I hope to identify gaps in current therapies and explore alternative or complementary approaches with fewer side effects, thereby potentially improving their quality of life.

Ethical considerations are central to my research design. I plan to adhere strictly to ethical standards outlined in the Belmont Report, ensuring that the protection of human subjects is prioritized throughout the study. In conducting interviews and collecting data, I will emphasize informed consent, confidentiality, and voluntary participation, crucial safeguards for vulnerable populations like the elderly. My choice of a mixed-methods approach allows for a comprehensive understanding of patient experiences and treatment impacts, blending quantitative data with qualitative insights. This method enhances the depth and breadth of the findings, ensuring they are both valid and applicable to real-world clinical settings.

To ensure the validity and reliability of my research, I will implement rigorous data collection and management protocols. Accurate data entry and secure storage will be emphasized to maintain data integrity. Appropriate statistical techniques, such as descriptive statistics and inferential tests, will be employed to analyze the relationship between treatment plans and quality of life outcomes. Variable measurement and data collection tools will be carefully selected and validated to produce credible results. By examining these aspects, I hope to generate evidence that could influence future treatment strategies, offering less toxic and more effective options for elderly patients with multiple myeloma.

The motivation behind choosing this research topic is deeply personal; my father’s experience with multiple myeloma has opened my eyes to the urgent need for better treatment options. His diminished mobility and prolonged bedridden episodes highlight the urgent necessity for therapies that not only target the disease but also prioritize the patient’s overall well-being. My goal is to contribute to this field by identifying interventions that balance efficacy with quality of life, particularly for vulnerable elderly populations. Ultimately, I aspire to advance research that informs clinical practice, ensuring patients like my father receive compassionate, effective, and tailored care that enhances their remaining years.

References

• Alexanian, R., & Buadi, F. (2019). Therapy for Multiple Myeloma in the Elderly. Hematology/Oncology Clinics of North America, 33(2), 423-436.
• Boyd, K., Murray, S. A. (2017). Bringing palliative and supportive care to patients with advanced cancer. British Medical Journal, 341, c1381.
• Hui, D., & Bruera, E. (2016). Models of integrated palliative care in the cancer setting. The Cancer Journal, 22(2), 84-89.
• Lahuerta, J. J., et al. (2020). Impact of treatment on health-related quality of life in elderly patients with multiple myeloma. Blood Advances, 4(24), 6123-6134.
• Rajkumar, S. V. (2020). Multiple myeloma: 2020 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 95(5), 548-567.
• Roodman, G. D. (2017). Mechanisms of Bone Disease in Multiple Myeloma. Hematology/Oncology Clinics of North America, 31(4), 679-691.
• Sivendran, S., et al. (2018). Management of Elderly Myeloma Patients. Clinical Advancements in Hematology & Oncology, 16(5), 242-252.
• Wang, T., et al. (2019). Ethical considerations in health research involving vulnerable populations. BMC Medical Ethics, 20, 41.
• World Health Organization. (2019). Ethical standards for health research involving human subjects. WHO Guidelines.
• Zimmerman, S., et al. (2018). Aging and Cancer: The Impact of Comorbidities and Treatment on Outcomes. The Journals of Gerontology: Series A, 73(2), 183-189.